These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry. Rigatelli G, Cardaioli P, Dell'avvocata F, Giordan M, Chinaglia M. Catheter Cardiovasc Interv; 2011 Mar 01; 77(4):564-9. PubMed ID: 20602480 [Abstract] [Full Text] [Related]
5. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder. Bartakian S, El-Said HG, Printz B, Moore JW. JACC Cardiovasc Interv; 2013 Sep 01; 6(9):974-80. PubMed ID: 24050864 [Abstract] [Full Text] [Related]
6. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results. Aytemir K, Oto A, Özkutlu S, Canpolat U, Kaya EB, Yorgun H, Şahiner L, Sunman H, Ateş AH, Kabakçı G. Congenit Heart Dis; 2013 Sep 01; 8(5):418-27. PubMed ID: 23601507 [Abstract] [Full Text] [Related]
7. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design. Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Chinaglia M, Roncon L. Cardiovasc Revasc Med; 2010 Sep 01; 11(1):29-33. PubMed ID: 20129358 [Abstract] [Full Text] [Related]
8. Safety and long-term outcome of modified intracardiac echocardiography-assisted "no-balloon" sizing technique for transcatheter closure of ostium secundum atrial septal defect. Rigatelli G, Dell'avvocata F, Cardaioli P, Giordan M, Dung HT, Nghia NT, Daggubati R, Nanjiundappa A. J Interv Cardiol; 2012 Dec 01; 25(6):628-34. PubMed ID: 22823449 [Abstract] [Full Text] [Related]
9. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients. Medford BA, Taggart NW, Cabalka AK, Cetta F, Reeder GS, Hagler DJ, Johnson JN. J Am Soc Echocardiogr; 2014 Sep 01; 27(9):984-90. PubMed ID: 24998516 [Abstract] [Full Text] [Related]
10. Transcatheter closure of multiple interatrial communications. Masseli J, Bertog S, Stanczak L, Blankenbach K, Majunke N, Reiffenstein I, Renkhoff K, Lehn K, Wunderlich N, Sievert H. Catheter Cardiovasc Interv; 2013 Apr 01; 81(5):825-36. PubMed ID: 22907918 [Abstract] [Full Text] [Related]
11. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique. Kammache I, Mancini J, Ovaert C, Habib G, Fraisse A. Catheter Cardiovasc Interv; 2011 Nov 01; 78(5):665-74. PubMed ID: 21812090 [Abstract] [Full Text] [Related]
12. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients. Heinisch C, Bertog S, Wunderlich N, Majunke N, Baranowski A, Leetz M, Fischer E, Staubach S, Zimmermann W, Hofmann I, Sievert H. EuroIntervention; 2012 Oct 01; 8(6):717-23. PubMed ID: 23086790 [Abstract] [Full Text] [Related]
13. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series. Rigatelli G, Dell'Avvocata F, Giordan M, Ronco F, Braggion G, Schenal N, Aggio S, Cardaioli P. J Cardiovasc Med (Hagerstown); 2010 Feb 01; 11(2):91-5. PubMed ID: 19829139 [Abstract] [Full Text] [Related]
14. [Intracardiac echocardiography-guided device closure of atrial septal defects: our initial experience]. Akkaya E, Vuruşkan E, Aksoy I, Ardıç I, Küçükosmanoğlu M, Ozer O. Turk Kardiyol Dern Ars; 2011 Sep 01; 39(6):474-8. PubMed ID: 21918317 [Abstract] [Full Text] [Related]
15. Impact of interatrial septum anatomic features on short- and long-term outcomes after transcatheter closure of patent foramen ovale: single device type versus anatomic-driven device selection strategy. Rigatelli G, Dell'avvocata F, Daggubati R, Dung HT, Nghia NT, Nanjiundappa A, Giordan M, Cardaioli P. J Interv Cardiol; 2013 Aug 01; 26(4):392-8. PubMed ID: 23941654 [Abstract] [Full Text] [Related]
16. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. Rigatelli G, Dell'Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Rigatelli G, Chen JP. JACC Cardiovasc Interv; 2010 Mar 01; 3(3):282-7. PubMed ID: 20298985 [Abstract] [Full Text] [Related]
18. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation. Loar RW, Johnson JN, Cabalka AK, Cetta F, Hagler DJ, Eidem BW, Taggart NW. Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1234-7. PubMed ID: 23239614 [Abstract] [Full Text] [Related]
19. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature. Manolis AS. Rev Recent Clin Trials; 2017 Jun 01; 12(2):129-138. PubMed ID: 28356032 [Abstract] [Full Text] [Related]